NCT04227626View on ClinicalTrials.gov

Inpatient Closed Loop Glucose Control With the Gen 2 GlucoSTAT

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2021

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Type 1 DiabetesType 2 Diabetes Treated With Insulin
Interventions
DEVICE

GlucoSTAT

Closed-loop blood glucose control using intravenous insulin and dextrose

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Beta Bionics, Inc.
All Listed Sponsors
collaborator

Beta Bionics, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER